TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BMEA

Biomea Fusion Inc

Healthcare · Biotechnology

1.80$ +2.2% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Biomea Fusion Inc (BMEA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 93.5% of the shares are freely tradable; institutional investors hold 38.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 38.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 7.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 93.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 20.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 72Mio.

Largest Shareholders

Institutions

Institutions BMEA
Name Stake (%) Shares Change (%) Date
FMR Inc 12.16 8,813,359 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.58 2,597,300 +0.0 03/31/2026
Aisling Capital Management LP 2.83 2,048,757 +0.0 06/30/2026
Renaissance Technologies Corp 1.81 1,312,798 +174.3 03/31/2026
Marshall Wace Asset Management Ltd 1.65 1,198,551 +3.3 03/31/2026

Funds

Funds BMEA
Name Stake (%) Shares Change (%) Date
Fidelity Growth Compy Commingled Pl S 5.43 3,937,054 +0.0 07/31/2026
Fidelity Growth Company Fund 3.74 2,708,445 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.93 2,122,086 +0.0 07/31/2026
Fidelity Growth Company K6 1.26 910,495 +0.0 07/31/2026
Fidelity Series Growth Company 1.11 804,702 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?